{"id":"https://openalex.org/W2040320720","doi":"https://doi.org/10.7164/antibiotics.55.337","title":"Oxidative Modification of NK30424A and B Enhance Inhibitory Effect on Lipopolysaccharide-induced Tumour Necrosis Factor-.ALPHA. Promoter Activity.","display_name":"Oxidative Modification of NK30424A and B Enhance Inhibitory Effect on Lipopolysaccharide-induced Tumour Necrosis Factor-.ALPHA. Promoter Activity.","publication_year":2002,"publication_date":"2002-01-01","ids":{"openalex":"https://openalex.org/W2040320720","doi":"https://doi.org/10.7164/antibiotics.55.337","mag":"2040320720","pmid":"https://pubmed.ncbi.nlm.nih.gov/12014450"},"language":"ja","primary_location":{"id":"doi:10.7164/antibiotics.55.337","doi":"https://doi.org/10.7164/antibiotics.55.337","is_oa":true,"landing_page_url":"https://doi.org/10.7164/antibiotics.55.337","pdf_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/55/3/55_3_337/_pdf","source":{"id":"https://openalex.org/S154771817","display_name":"The Journal of Antibiotics","issn_l":"0021-8820","issn":["0021-8820","1881-1469"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Antibiotics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/55/3/55_3_337/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064513906","display_name":"Yoshiyuki Takayasu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150228","display_name":"Nippon Kayaku (Japan)","ror":"https://ror.org/05cbf4214","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210150228"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"YOSHIYUKI TAKAYASU","raw_affiliation_strings":["Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co, Ltd, Tokyo, Japan. yoshiyuki.takayasu@nipponkayaku.co.jp","Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co, Ltd, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co, Ltd, Tokyo, Japan. yoshiyuki.takayasu@nipponkayaku.co.jp","institution_ids":["https://openalex.org/I4210150228"]},{"raw_affiliation_string":"Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co, Ltd, Tokyo, Japan","institution_ids":["https://openalex.org/I4210150228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109186140","display_name":"KOUICHI TSUCHIYA","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150228","display_name":"Nippon Kayaku (Japan)","ror":"https://ror.org/05cbf4214","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210150228"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"KOUICHI TSUCHIYA","raw_affiliation_strings":["Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd","institution_ids":["https://openalex.org/I4210150228"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090460998","display_name":"Yoshikazu Sukenaga","orcid":"https://orcid.org/0000-0001-8479-3842","observed_orcids":["https://orcid.org/0000-0001-8479-3842"]},"institutions":[{"id":"https://openalex.org/I4210150228","display_name":"Nippon Kayaku (Japan)","ror":"https://ror.org/05cbf4214","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210150228"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"YOSHIKAZU SUKENAGA","raw_affiliation_strings":["Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd","institution_ids":["https://openalex.org/I4210150228"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210150228"],"apc_list":{"value":4590,"currency":"USD","value_usd":4590},"apc_paid":null,"fwci":0.6712,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.6398929,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"55","issue":"3","first_page":"337","last_page":"340"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10252","display_name":"Microbial Natural Products and Biosynthesis","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10252","display_name":"Microbial Natural Products and Biosynthesis","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12257","display_name":"Bioactive natural compounds","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oxidative-modification","display_name":"oxidative modification","score":0.7699999809265137},{"id":"https://openalex.org/keywords/lipopolysaccharide","display_name":"lipopolysaccharide","score":0.9110000133514404},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9449999928474426},{"id":"https://openalex.org/keywords/tnf-alpha-inhibitors","display_name":"TNF-alpha inhibitors","score":0.8289999961853027},{"id":"https://openalex.org/keywords/streptomyces","display_name":"Streptomyces","score":0.875},{"id":"https://openalex.org/keywords/natural-product-inhibitors","display_name":"natural product inhibitors","score":0.5230000019073486}],"concepts":[{"id":"https://openalex.org/C2778754761","wikidata":"https://www.wikidata.org/wiki/Q421804","display_name":"Lipopolysaccharide","level":2,"score":0.7336509227752686},{"id":"https://openalex.org/C17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","level":2,"score":0.6351815462112427},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.6068736910820007},{"id":"https://openalex.org/C64943373","wikidata":"https://www.wikidata.org/wiki/Q2651003","display_name":"Alpha (finance)","level":4,"score":0.5514340996742249},{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.5086179971694946},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5048673748970032},{"id":"https://openalex.org/C57600042","wikidata":"https://www.wikidata.org/wiki/Q227564","display_name":"Oxidative phosphorylation","level":2,"score":0.46039196848869324},{"id":"https://openalex.org/C503630168","wikidata":"https://www.wikidata.org/wiki/Q178069","display_name":"Necrosis","level":2,"score":0.45536038279533386},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4488966763019562},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3300514221191406},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.32441872358322144},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3161785304546356},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.29815220832824707},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.29527974128723145},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.24920737743377686},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15460607409477234},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.1459137499332428},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003545","descriptor_name":"Cysteine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003545","descriptor_name":"Cysteine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003545","descriptor_name":"Cysteine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D007783","descriptor_name":"Lactones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007783","descriptor_name":"Lactones","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D008070","descriptor_name":"Lipopolysaccharides","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D008070","descriptor_name":"Lipopolysaccharides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008264","descriptor_name":"Macrophages","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009682","descriptor_name":"Magnetic Resonance Spectroscopy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010084","descriptor_name":"Oxidation-Reduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011401","descriptor_name":"Promoter Regions, Genetic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011401","descriptor_name":"Promoter Regions, Genetic","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D014162","descriptor_name":"Transfection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.7164/antibiotics.55.337","doi":"https://doi.org/10.7164/antibiotics.55.337","is_oa":true,"landing_page_url":"https://doi.org/10.7164/antibiotics.55.337","pdf_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/55/3/55_3_337/_pdf","source":{"id":"https://openalex.org/S154771817","display_name":"The Journal of Antibiotics","issn_l":"0021-8820","issn":["0021-8820","1881-1469"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Antibiotics","raw_type":"journal-article"},{"id":"pmid:12014450","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12014450","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of antibiotics","raw_type":"Journal Article"},{"id":"pmid:12199118","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12199118","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Japanese journal of antibiotics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.7164/antibiotics.55.337","doi":"https://doi.org/10.7164/antibiotics.55.337","is_oa":true,"landing_page_url":"https://doi.org/10.7164/antibiotics.55.337","pdf_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/55/3/55_3_337/_pdf","source":{"id":"https://openalex.org/S154771817","display_name":"The Journal of Antibiotics","issn_l":"0021-8820","issn":["0021-8820","1881-1469"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Antibiotics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2040320720.pdf","grobid_xml":"https://content.openalex.org/works/W2040320720.grobid-xml"},"referenced_works_count":3,"referenced_works":["https://openalex.org/W2000832822","https://openalex.org/W2027260180","https://openalex.org/W2105415988"],"related_works":["https://openalex.org/W2953125432","https://openalex.org/W2952690537","https://openalex.org/W2119906870","https://openalex.org/W5507761","https://openalex.org/W2138402725","https://openalex.org/W7097752012","https://openalex.org/W4236340827","https://openalex.org/W2124840287","https://openalex.org/W1977565920","https://openalex.org/W2062959604"],"abstract_inverted_index":{"Novel":[0],"potent":[1],"inhibitors":[2],"of":[3,17],"lipopolysaccharide":[4],"(LPS)induced":[5],"tumor":[6],"necrosis":[7],"factor":[8],"(TNF)-\u03b1":[9],"promoter":[10],"activitywere":[11],"isolated":[12],"from":[13],"the":[14],"culture":[15],"broth":[16],"Streptomyces":[18],"sp.NA30424.Previously,":[19],"we":[20],"discovered":[21],"TNF-\u03b1":[22],"inhibitors,":[23]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}